FIERCELY FOCUSED
ON PATIENTS

Eligible Organizations

—–●–Funding is permitted to qualified U.S. based nationally accredited healthcare and academic organizations only.

—–●–Requesting organization should have an established fellowship training program that aligns with the Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology.

—–●–Requesting organization must confirm receipt of payment.

—–●–Requesting organization must verify how funds were used for all medical education grants, sponsorships and fellowships previously supported by TG.

—–●–Requesting organization and fellowship request must be in full compliance with all regional and local codes, laws and industry regulations, including, but not limited to anti-corruption, transparency and privacy laws and regulations.

 

Ineligible organizations and people

—–●–Physician group practices, physician-owned clinics, managed care organizations, pharmacy benefits managers or hospitals that are not academic medical centers cannot receive fellowship funding.

—–●–Fellowship cannot be awarded directly to an individual fellow.

0000000

—–●-Fellowship Program must:

—–●–Provide a comprehensive clinical program allowing a fellow to demonstrate his/her learned skills and competencies;

—–●–Have a clear and defined development plan for the fellow;

—–●–Focus on building the clinical skills of the fellow;

—–●–Provide training using multi-disciplinary teams;

—–●–Utilize faculty who devote sufficient time to fulfill their supervisory and teaching responsibilities;

—–●–Be no more than one academic year and;

—–●–Not be renewed for a fellow previously selected by the organization using TG funds.

 

0000000

—–●-Fellowship Candidates must:

—–●–Have a sponsor who is a full-time faculty member of the requesting organization;

—–●–Not hold a full-time, tenure-track faculty position or its equivalent during the first year of the fellowship;

—–●–Be U.S. Board certified or Board eligible in Neurology;

—–●–Multiple Sclerosis Clinical Fellowship candidates must hold an active license in good standing and;

—–●–Funding should not support training and development of Non-HCPs.

 

0000000

Submission timeline

—–●–Requests for clinical fellowships will be accepted and reviewed annually in the year prior to the actual fellowship period. Fellowship applications will be accepted from July 1 – August 15, 2024. All decisions will be communicated in September 2024.

—–●–Applications should be emailed to: [email protected]

 

 

Information to provide in the application

—–●–General information
—————–-Type of fellowship, program start and end date, program title, brief overview/description of fellowship program to include number of fellows anticipated for current training period, history of the program, previous fellows trained, and amount of funding requested

—–●–Needs assessment summary
——————-Describe the need that the fellowship will address (i.e. increase diversity amongst MS trained providers)

—–●–Learning objectives and training plan
——————– Describe didactic learning, hands-on learning (to include description of in-patient and out-patient learning), and multidisciplinary approach to care (to include consideration of how fellows might interact or engage in outside educational opportunities and how they will work with other disciplines within the institution)

—–●–Outcomes measurement plan
——————-Describe how fellows will be evaluated and measures used to define successful training and development

—–●–Itemized budget
——————-Describe how budget will be used to support training (i.e. salary, benefits, educational courses) and where additional funding support will come from

—–●–A Letter of request from fellowship program director must be submitted on institutional letterhead and include a description of the faculty commitment to training and anticipated time that faculty will devote to training and supervising fellows.

—–●–The requesting organization must make a compliance commitment stating that in the event a fellowship program is funded by TG Therapeutics the support from TG  will be disclosed and that none of the funds provided will be used for billable teaching/research work. 

 

0000000

—–●–Fellowship request must be unsolicited.

—–●–Fellowship request must not provide tangible benefit to TG.

—–●–Fellowship request must be submitted for a future program.

—–●–Funding from other pharmaceutical/biotechnology companies, in addition to TG, to support the program is preferred (e.g. multiple sources of funding).

—–●–Funds are not granted to directly or indirectly encourage recipients to purchase or prescribe TG’s products or services.

—–●–TG cannot have a role in selecting the fellowship recipient.

—–●–TG will conduct appropriate due diligence on all requesting organizations and fellowship requests.

—–●–TG reserves the right to deny any fellowship request.

—–●–TG may not require, as part of the support, that the fellow spend his/her time at the company or provide company-related services.

—–●–TG must not provide any substantive input or assistance to a requesting organization in drafting or submitting a grant request.

—–●–TG may modify the fellowship application and eligibility requirements at any time.

—–●–TG will conduct an administrative review to ensure application is complete and no additional information is needed.

—–●–Funding decisions for fellowships are made through a formal, centralized review and decision-making process.

—–●–Funding decisions for fellowships are based on the quality of the proposal, alignment with TG’s grants strategy, and budget availability.

—–●–Decision notifications will be communicated in writing.

—–●–Award up to $100,000 per academic year to directly support salaries and limited fringe benefits of fellows.

—–●–Organizations may not use awarded funds to defray operating expenses.

 

0000000

—–●–A Letter of Agreement (LOA) will be provided.

————●–Recipients must abide by terms and conditions as outlined in the LOA.

————●–LOA will be issued electronically to an authorized signatory of the organization once an application is approved.

————●–Fully executed LOA is required prior to the start of the program.

—–●–Payment will be issued upon execution of the LOA and the organization’s submission of the required information, including W9, requestor’s conflict of interest statement, and firewall policy or statement.

—–●– Changes to an awarded fellowship must be reviewed and approved prior to the start of the program. To determine if funding may continue, organizations should submit the proposed changes for review.

 

 

0000000

—–●–Once the fellowship concludes, a reconciliation must be completed by the recipient organization. The reconciliation confirms:

————–●–Receipt of payment;

————–●–Funding was used appropriately (as described in the LOA;)

————–●–Fellowship objectives were achieved and;

————–●–Fellow’s training and development plan was achieved.

—–●–This reconciliation must be completed and returned to TG within 90 days of the program end date. After 90 days, the reconciliation is considered overdue. Recipient organizations are not eligible to receive new funding until all overdue reconciliations are submitted.

 

0000000